Skip to main content

Advertisement

Log in

Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism

  • Nephrology - Original article
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Introduction

The life for end-stage renal disease patients has remarkably improved in the last years. Although mineral and bone disorders remain as unsolved complication, in severe secondary hyperparathyroidism (sHPT), the ultimate treatment is parathyroidectomy (PTX). It is an old treatment, but there are still insufficient data regarding survival after PTX. The study goals were to compare 2-year mortality and morbidity after PTX in surgically versus medically treated sHPT and to compare the efficacy and safety in subtotal versus total PTX in a cohort of patients receiving hemodialysis (HD).

Methods

This prospective, longitudinal study was carried out on a cohort of chronic HD patients with severe sHPT (iPTH over 700 pg/ml). Among the overall HD population, 26 patients underwent PTX. This group was compared to a control group treated with specific drugs. Laboratory parameters, specific symptoms and mortality were registered after 24 months of follow-up for each group. The subgroups of subtotal and total PTX patients were also compared.

Results

All average values of mineral markers were significantly reduced after PTX, as a proof that surgical treatment was effective. The reduction in mineral markers and the improvement in symptoms and mortality rates were similar after total and subtotal PTX. Bone pain was significantly lower in patients after PTX than in those drug treated (p = 0.0005), but not muscle weakness and itching. Survival at 2 years was better in patients surgically treated (PTX) despite significantly higher mean baseline values of iPTH, Ca and ALP compared to patients medically treated (p = 0.03).

Conclusions

We compared clinical and laboratory outcomes in HD patients with severe sHPT. Mortality, bone pain and mineral markers were improved by PTX. Total and subtotal PTX had similar clinical outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(suppl 3):S1–S202

    Google Scholar 

  2. Eknoyan G, Levin A, Levin NW (2003) Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):1

    Article  Google Scholar 

  3. Al Aly Z, Gonzalez EA, Martin KJ et al (2004) Achieving K/DOQI laboratory target values for bone and mineral metabolism: an uphill battle. Am J Nephrol 24:422–426

    Article  PubMed  Google Scholar 

  4. Elder G (2005) Parathyroidectomy in the calcimimetic era. Nephrology 10:511–515

    Article  CAS  PubMed  Google Scholar 

  5. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1–S130

    Google Scholar 

  6. Fernández-Martín JL, Martínez-Camblor P, Dionisi MP et al (2015) Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant 30(9):1542–1551

    Article  PubMed  Google Scholar 

  7. Tentori F, Blayney MJ, Albert JM et al (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52:519–530

    Article  CAS  PubMed  Google Scholar 

  8. Kestenbaum B, Andress DL, Schwartz SM et al (2004) Survival following parathyroidectomy among United States Dialysis patients. Kidney Int 66:2010–2016

    Article  PubMed  Google Scholar 

  9. Goldfarb M, Gondek SS, Lim SM, Farra JC, Nose V, Lew JI (2012) Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin. World J Surg 36:1314–1319

    Article  PubMed  Google Scholar 

  10. Covic A, Apetrii M, Heymann EP, Goldsmith D (2012) Medical and surgical management (including diet). Clin Rev Bone Miner Metab 10(3):174–183

    Article  Google Scholar 

  11. Ishani A, Liu J, Wetmore JB et al (2015) Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis. Clin J Am Soc Nephrol 10(1):90–97

    Article  CAS  PubMed  Google Scholar 

  12. Komaba H, Taniguchi M, Wada A et al (2015) Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int. doi:10.1038/ki.2015.72

    Google Scholar 

  13. Ma TL, Hung PH, Jong IC et al (2015) Parathyroidectomy is associated with reduced mortality in hemodialysis patients with secondary hyperparathyroidism. BioMed Res Int. doi:10.1155/2015/639587

    Google Scholar 

  14. Trombetti A, Stoermann C, Robert JH et al (2007) Survival after parathyroidectomy in patients with end-stage renal disease and severe hyperparathyroidism. World J Surg 15:1014–1021

    Article  Google Scholar 

  15. Costa-Hong V, Jorgetti V, Henrique L et al (2007) Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery 142(5):699–703

    Article  PubMed  Google Scholar 

  16. Dussol B, Morand P, Martinat C et al (2007) Influence of parathyroidectomy on mortality in hemodialysis patients: a prospective observational study. Ren Fail 29(5):579–586

    Article  CAS  PubMed  Google Scholar 

  17. Bleyer AJ, Burkart J, Piazza M et al (2005) Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD. Am J Kidney Dis 46:464

    Article  PubMed  Google Scholar 

  18. Slinin Y, Foley R, Collins AJ (2005) Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16:1788–1793

    Article  CAS  PubMed  Google Scholar 

  19. Miskulin D, Bragg-Gresham J, Gillespie BW et al (2009) Key comorbid conditions that are predictive of survival among hemodialysis patients. Clin J Am Soc Nephrol 4:1818

    Article  PubMed Central  PubMed  Google Scholar 

  20. Yeun JY, Levine RA, Mantadilok V, Kaysen GA (2000) C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35:469

    Article  CAS  PubMed  Google Scholar 

  21. Mazzaferro S, Pasquali M, Farcomeni A et al (2008) Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQITM ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients. Nephrol Dial Transplant 23(7):2319–2323

    Article  CAS  PubMed  Google Scholar 

  22. Tsai WC, Peng YS, Chiu YL et al (2015) Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol 47(7):1203–1207

    Article  CAS  PubMed  Google Scholar 

  23. Cheng SP, Lee JJ, Liu TP et al (2014) Parathyroidectomy improves symptomatology and quality of life in patients with secondary hyperparathyroidism. Surgery 155(2):320–328

    Article  PubMed  Google Scholar 

  24. Sadideen HM, Taylor JD, Goldsmith D (2012) Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up. Int Urol Nephrol 44(1):275–281

    Article  PubMed  Google Scholar 

  25. Schlosser K, Veit JA, Witte S et al (2007) Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial. Trials 8:22. doi:10.1186/1745-6215-8-22

    Article  PubMed Central  PubMed  Google Scholar 

  26. Iwatomo N, Sato N, Nishida M et al (2012) Total parathyroidectomy improves survival of hemodialysis patients with secondary hyperparathyroidism. J Nephrol 25:755

    Article  Google Scholar 

  27. He Q, Zhu J, Zhuang D, Fan Z et al (2015) Robotic total parathyroidectomy by the axillo-bilateral-breast approach for secondary hyperparathyroidism: a feasibility study. J Laparoendosc Adv Surg Tech 25(4):311–313

    Article  Google Scholar 

  28. Tominaga Y, Katayama A, Sato T et al (2003) Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant 18(Suppl 3):iii65–iii70

    PubMed  Google Scholar 

  29. Sharma J, Raggi P, Kutner N et al (2012) Improved long-term survival of dialysis patients after near-total parathyroidectomy. J Am Coll Surg 214(4):400–407 (discussion 407–408)

    Article  PubMed Central  PubMed  Google Scholar 

  30. Tsai WC, Peng YS, Yang JY et al (2013) Short- and long-term impact of subtotal parathyroidectomy on the achievement of bone and mineral parameters recommended by clinical practice guidelines in dialysis patients: a 12-year single-center experience. Blood Purif 36(2):116–121

    Article  PubMed  Google Scholar 

  31. Yang YL, Lu HF, Chung KC, Jawan B, Chou FF (2015) Young age, male sex, and end-stage renal disease with secondary hyperparathyroidism as risk factors for intraoperative hyperkalemia during parathyroidectomy. J Clin Anesth 27(3):195–200

    Article  PubMed  Google Scholar 

  32. Kuo LE, Wachtel H, Karakousis G, Fraker D, Kelz R (2014) Parathyroidectomy in dialysis patients. J Surg Res 190(2):554–558

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This paper was published under the frame of European Social Fund, Human Resources Development Operational Program 2007–2013, Project No. POSDRU/159/1.5/138776.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Diana Moldovan.

Ethics declarations

Conflict of interest

The authors have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moldovan, D., Racasan, S., Kacso, I.M. et al. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism. Int Urol Nephrol 47, 1871–1877 (2015). https://doi.org/10.1007/s11255-015-1106-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-015-1106-x

Keywords

Navigation